Drug Administration Law (2019) — Drug Packaging and Labeling Requirements · Yalla China
قانون إدارة الأدوية (تعديل 2019) — متطلبات الترميز والتعليب / Drug Administration Law (2019) — Labeling Requirements
Enacted: 2019-08-26 ✅ Effective: 2019-12-01
📝 Overview
The Drug Administration Law defines drug management, licensing, packaging, and sale requirements in China including imported drugs.
This is general information only, not legal advice. For your specific case, consult a licensed lawyer.
📜 The law text / key provisions
The Drug Administration Law (2019) packaging provisions provide: (1) Drug registration: all drugs marketed in China must be registered with National Medical Products Administration (NMPA); (2) Packaging and labeling: drugs must carry Chinese-language label detailing components, dosage, and warnings; (3) Imported drugs: must obtain NMPA registration certificate; (4) E-commerce: prescription drugs generally prohibited from online sale; (5) Drug storage: storage and transport at approved temperatures mandatory.
💬 Practical reading
💬 This is a general reading/opinion for orientation — not the official legal text nor legal advice.
Do not bring or sell drugs in China without NMPA registration. Bringing quantities of prescription drugs for personal use requires clear medical documentation.
📎 Official source
National People's Congress of China
🕒 Updated: 16 March 2026